Reflection paper on the dissolution specification …
considered: 80 • Selection of a suitable dissolution medium should be based on the physico- chemical characteristics 81 of the active substance(s) and the intended dose range of the drug pr oduct to be tested.
Download Reflection paper on the dissolution specification …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
The Thermodynamics of the Dissolution of Urea
hwscience.comThe Thermodynamics of the Dissolution of Urea Background We know that chemical reactions proceed with the evolution or absorption of heat. This heat
The Development and Validation of a Dissolution …
www.dissolutiontech.com20 Dissolution Technologies| AUGUST 2004 Consequently,the in-house development of a precise,vali-dated,and reliable dissolution method for clomipramine solid oral dosage forms was necessary in order to support
dx.doi.org/10.14227/DT190412P36 Development …
www.dissolutiontech.comDissolution Technologies | NOVEMBER 201237 ability is the precision of the method under the same operating conditions over a short time. Reproducibility determines the precision between laboratories.
DECISION TREE #1: ESTABLISHING ACCEPTANCE …
www.ich.orgDECISION TREE #3: SETTING ACCEPTANCE CRITERIA FOR DRUG SUBSTANCE PARTICLE SIZE DISTRIBUTION Is the drug product a solid dosage form or liquid containing undissolved
ANNEX 10 - UNECE Homepage
www.unece.org- 549 - Annex 10 GUIDANCE ON TRANSFORMATION/DISSOLUTION OF METALS AND METAL COMPOUNDS IN AQUEOUS MEDIA1 A10.1 Introduction A10.1.1 This Test Guidance is designed to ...